The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3, 2002, Pages 357-361

  Szyllo, K ^a   Smolarz, Beata ^a   Romanowicz Makowska, H ^a   Niewiadomski, M ^a   Kozlowska, E ^a   Kulig, A ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Matrix metalloproteinase 3 (MMP 3); MMP 3 gene; Ovarian cancer; PCR; Polymorphism of promoter region

Indexed keywords

PROTEINASE; STROMELYSIN; TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; CANCER CELL; CANCER STAGING; CELL INVASION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN DEGRADATION;

AGED; AGED, 80 AND OVER; ALLELES; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0036740041     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Van Noorden J.F., Meade-Tollin L.C., Bosman F.T.: Metastasis. Am. Sci. 86: 130-141, 1998.
2. Dano K., Romer J., Nielsen B.S., Bjorn S., Pyke C., Rygaard J., Lund R.: Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS. 107: 120-127, 1999.
3. Meyer T., Hart I.R.: Mechanisms of tumour metastasis. Eur. J. Cancer 34: 214-221, 1998.
4. Mignatti P., Rifkin D.B.: Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73: 161-195, 1993.
5. Henriet P., Blavier L., DeClerek Y.A.: Tissue inhibitors of metalloproteinases (TIMP) and proliferation. APMIS. 107: 111-119, 1999.
6. Behrens J.: The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res. Treat. 24: 175-184, 1993.
7. Chambers A.F., Matrisian L.M.: Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89: 1260-1270, 1997.
8. Berek J.S., Fu Y.S., Hacker N.F: Ovarian cancer. In: Berek J.S., Adashi E.Y., Hillard P.A., eds. Novak's Gynecology. Baltimore: Williams & Wilkins, 1996: 1155-1230.
9. Bodey B., Bodey B.Jr., Siegel S.E., Kaiser H.E.: Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. In-Vivo 15: 57-64, 2001.
10. Kolomecki K., Stepien H., Bartos M., Kuzdak K.: Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours. Endocr. Regul. 35: 9-16, 2001.
11. Balduyck M., Zerimech F., Gouyer V., Lemaire R., Hemon B., Grard G., Thiebaut C., Lemaire V., Dacquembronne E., Duhem T., Lebrun A., Dejonghe M.J., Huet G.: Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin. Exp. Metastasis 18: 171-178, 2000.
12. Bodey B., Bodey B. Jr., Siegel S.E., Kaiser H.E.: Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas. In-Vivo 15: 71-76, 2001.
13. Bodey B., Bodey B.Jr., Siegel S.E., Kaiser H.E.: Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer. In-Vivo 15: 65-70, 2001.
14. Birkedal-Hansen B., Pavelic Z.P., Gluckman J.L., Stambrook P., Li Y.Q., Stetler-Stevenson W.G.: MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral. Dis. 6: 376-382, 2000.
15. Baruch R.R., Melinscak H., Lo J., Liu Y., Yeung O., Hurta R.A.: Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation. Cell. Biol. Int. 25: 411-420, 2001.
16. Borden P., Heller R.: Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryotic Gene Expr. 7: 159-178, 1997.
17. Delany A.M., Brinckerhoff C.E.: Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblast. J. Cell Biochem. 50: 400-410, 1990.
18. Yoon S., Tromp G., Vongpunsawad., Ronkainen A., Juvonen T., Kuivaniemi H.: Genetic analysis of MMP-3, MMP-9 and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem. Biophys. Res. Commun. 265: 563-568, 1999.
19. Satsangi J., Chapman R.W., Haldar N., Donaldson P., Mitchell S., Simmons J., Norris S., Marshall S.E., Bell J.I., Jewell D.P., Welsh K.I.: A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121: 124-130, 2001.
20. Buttice G., Duterque-Coquillaud M., Basuyaux J.P., Carrere S., Kurkinen M., Stehelin D.: Erg and Ets family member, differentially regulates human collagenase-1 (MMP-1) and stromelysin 1 (MMP-3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13: 2297-2306, 1996.
21. White L.A., Maute C., Brinckerhoff C.E.: Ets sites in the promoters of the matrix metallo-proteinases collagenase (MMP-1), stromelysin (MMP-3) are auxilliary elements that regulate basal and phorbol-induced transcription. Connect. Tissue Res. 36: 321-335, 1997.
22. Wasylyk B., Hahn S.L., Giovane A.: The Ets family of transcription factors. Eur. J. Biochem. 211: 7-18, 1993.
23. Sapi E., Flick M., Rodov S., Kancinski B.: Ets-2 transdominant mutant abolishes anchorage-independent and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res. 58: 1027-1033, 1998.
24. Benbow U., Brinckerhoff C.E.: The AP1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15: 519-526, 1997.
25. Muller D., Li D.Q., Tseng S.C.: Regulation of collagenase, stromelysin and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin 1-beta and tumor necrosis factor alpha. Invest. Ophthalmol. Vis. Sci. 41: 2922-2929, 2000.